Navigation Links
AMDL's First Full Service JPGreen Health and Personal Care Center Set to Open in Hangzhou, China
Date:12/19/2007

TUSTIN, Calif., Dec. 19 /PRNewswire-FirstCall/ -- AMDL, Inc., (Amex: ADL), today announced that its subsidiary, Jade Pharmaceutical Inc., a developer, manufacturer, and marketer of pharmaceutical, nutraceutical, diagnostic, consumer healthcare and personal care products, is set to open its first large-scale JPGreen Health and Personal Care Center in Hangzhou, China. The state-of-the-art facility was acquired by Jade to be converted into a flagship JPGreen Health and Personal Care Center.

Customers will experience full service personal health care, which will include the anti-aging treatment with Jade's award winning Goodnak(R) product. The Hangzhou Center is the first full service location of an anticipated 200 JPGreen Health and Personal Care Centers. "Individual locations are expected to have an average gross profit margin of 70% and these Care Centers will add significantly to our sales. We previously announced that Goodnak(R) distributor sales alone are on a path to deliver revenues as high as $24 million over the next 12 months," said Frank Zhen, managing director.

Gary Dreher, CEO of AMDL, said that the "previous distributor network of sales and the new non distributor revenue provided by Jade's own growing consumer health and personal care business complement the Company's other already profitable product lines. We are building on the significant success we achieved in China this past quarter."

About AMDL: More information about AMDL and its products can be obtained at http://www.amdl.com.

About Jade: Jade has access to the fastest growing pharmaceutical and consumer market in the world: China. AMDL, through its Jade subsidiaries, currently holds licenses for 133 products that are manufactured as large volume injection fluids, tablets and other related products. It currently manufactures over 20 key generic, over the counter and supplemental pharmaceutical products under certified Chinese Good Manufacturing Practice (CGMP) standards.

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks and uncertainties, and actual circumstances, events or results may differ materially from those projected in such forward-looking statements. The Company cautions readers not to place undue reliance on any forward-looking statements. The Company does not undertake, and specifically disclaims any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.

Contact: AMDL, Inc.

Mr. Paul Knopick

AMDL Investor Relations

Direct Line: 949.707.5365

VoiceMail: 714.505.4460


'/>"/>
SOURCE AMDL, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
3. Kewaunee Scientific Announces First Quarter Results and Quarterly Dividend
4. Genmab Announces 2007 First Half Year Results
5. Pharsight Achieves First License Sale for Public-Source Database
6. Novare Announces First Ever Single Port Laparoscopic Kidney Removal (Nephrectomy) Using RealHand(TM) HD Instruments
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. China Medical Technologies Reports First Quarter Financial Results
9. Pressure BioSciences, Inc. Issued First Patent in Canada
10. Peregrine Pharmaceuticals to Announce First Quarter FY 2008 Financial Results
11. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... , ... February 09, 2016 , ... The American ... organization’s history, it is offering its 2016 AAT Member Certification Qualification Course for Technicians ... curriculum for the webinar, which will include a detailed review of hardware, software, and ...
(Date:2/9/2016)... , Feb. 9, 2016 This market ... the current and future prospects of the market in ... report include companies engaged in the manufacture of microbiology ... executive summary with a market snapshot providing the overall ... of this report. This section also provides the overall ...
(Date:2/9/2016)... Feb. 9, 2016 ... 2016", report provides in depth insights on ... around the Protein-Tyrosine Phosphatase 1B (PTP1B) Inhibitors. ... in various stages of development including Discovery, ... III and Preregistration. Report covers the product ...
(Date:2/8/2016)... 2016 --> ... innovation-driven oncology company developing next generation cancer therapeutics ... announced that chairman emeritus of Tata Sons Limited, ... company as part of the first close of ... Navam Capital and Aarin Capital. http://photos.prnewswire.com/prnh/20150923/766442 ...
Breaking Biology Technology:
(Date:1/21/2016)... PUNE, India , January 21, 2016 /PRNewswire/ ... According to a new market research report "Emotion ... Learning, and Others), Software Tools (Facial Expression, Voice ... and Regions - Global forecast to 2020", published ... Market is expected to reach USD 22.65 Billion ...
(Date:1/15/2016)... SAN JUAN, Puerto Rico , Jan. 15, 2016 ... forcing companies big and small to find new ways ... data driven culture. iOS and ... their device based on biometrics, transforming it into a ... can request that users swipe their fingerprint on their ...
(Date:1/8/2016)... United Kingdom , Jan. 8, 2016   Bruin ... products, today announced the closing of a $9 million financing. ... from the financing will be used to accelerate the commercialization ... detecting early-stage pressure ulcers. United Kingdom ... CE Mark approval. The device,s introduction has been met with ...
Breaking Biology News(10 mins):